Literature DB >> 16604138

What can metabolic myopathies teach us about exercise physiology?

Mark A Tarnopolsky1.   

Abstract

Exercise physiologists are interested in metabolic myopathies because they demonstrate how knocking out a component of a specific biochemical pathway can alter cellular metabolism. McArdle's disease (myophosphorylase deficiency) has often been studied in exercise physiology to demonstrate the influence of removing the major anaerobic energy supply to skeletal muscle. Studies of patients with McArdle's disease have shown the increased reliance on blood-borne fuels, the importance of glycogen to maximal aerobic capacity, and the use of nutritional strategies to bypass metabolic defects. Myoadenylate deaminase deficiency is the most common metabolic enzyme deficiency in human skeletal muscle. It is usually compensated for endogenously and does not have a major influence on high-energy power output. Nutritional interventions such as carbohydrate loading and carbohydrate supplementation during exercise are essential components of therapy for patients with fatty acid oxidation defects. Cases of mitochondrial myopathies illustrate the importance of peripheral oxygen extraction for maximal aerobic capacity and show how both exercise and nutritional interventions can partially compensate for these mutations. In summary, metabolic myopathies provide important insights into regulatory and nutritional aspects of the major biochemical pathways of intermediary metabolism in human skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16604138     DOI: 10.1139/h05-008

Source DB:  PubMed          Journal:  Appl Physiol Nutr Metab        ISSN: 1715-5312            Impact factor:   2.665


  6 in total

1.  Targeted Therapies for Metabolic Myopathies Related to Glycogen Storage and Lipid Metabolism: a Systematic Review and Steps Towards a 'Treatabolome'.

Authors:  A Manta; S Spendiff; H Lochmüller; R Thompson
Journal:  J Neuromuscul Dis       Date:  2021

2.  Diagnostic Algorithm for Glycogenoses and Myoadenylate Deaminase Deficiency Based on Exercise Testing Parameters: A Prospective Study.

Authors:  Fabrice Rannou; Arnaud Uguen; Virginie Scotet; Cédric Le Maréchal; Odile Rigal; Pascale Marcorelles; Eric Gobin; Jean-Luc Carré; Fabien Zagnoli; Marie-Agnès Giroux-Metges
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

3.  Effects of AMPD1 common mutation on the metabolic-chronotropic relationship: Insights from patients with myoadenylate deaminase deficiency.

Authors:  Fabrice Rannou; Virginie Scotet; Pascale Marcorelles; Roxane Monnoyer; Cédric Le Maréchal
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

4.  Higher oxidative stress in skeletal muscle of McArdle disease patients.

Authors:  Jan J Kaczor; Holly A Robertshaw; Mark A Tarnopolsky
Journal:  Mol Genet Metab Rep       Date:  2017-06-09

5.  Exercise efficiency impairment in metabolic myopathies.

Authors:  Jean-Baptiste Noury; Fabien Zagnoli; François Petit; Pascale Marcorelles; Fabrice Rannou
Journal:  Sci Rep       Date:  2020-05-29       Impact factor: 4.379

Review 6.  The Application of Creatine Supplementation in Medical Rehabilitation.

Authors:  Kylie K Harmon; Jeffrey R Stout; David H Fukuda; Patrick S Pabian; Eric S Rawson; Matt S Stock
Journal:  Nutrients       Date:  2021-05-27       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.